These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 14580201

  • 21. Hsp90: chaperoning signal transduction.
    Richter K, Buchner J.
    J Cell Physiol; 2001 Sep; 188(3):281-90. PubMed ID: 11473354
    [Abstract] [Full Text] [Related]

  • 22. The Hsp90 molecular chaperone: an open and shut case for treatment.
    Pearl LH, Prodromou C, Workman P.
    Biochem J; 2008 Mar 15; 410(3):439-53. PubMed ID: 18290764
    [Abstract] [Full Text] [Related]

  • 23. The Mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37).
    Roe SM, Ali MM, Meyer P, Vaughan CK, Panaretou B, Piper PW, Prodromou C, Pearl LH.
    Cell; 2004 Jan 09; 116(1):87-98. PubMed ID: 14718169
    [Abstract] [Full Text] [Related]

  • 24. Hsp90 functions to balance the phosphorylation state of Akt during C2C12 myoblast differentiation.
    Yun BG, Matts RL.
    Cell Signal; 2005 Dec 09; 17(12):1477-85. PubMed ID: 15935620
    [Abstract] [Full Text] [Related]

  • 25. Cdc37-Hsp90 complexes are responsive to nucleotide-induced conformational changes and binding of further cofactors.
    Gaiser AM, Kretzschmar A, Richter K.
    J Biol Chem; 2010 Dec 24; 285(52):40921-32. PubMed ID: 20880838
    [Abstract] [Full Text] [Related]

  • 26. Analysis of the CK2-dependent phosphorylation of serine 13 in Cdc37 using a phospho-specific antibody and phospho-affinity gel electrophoresis.
    Miyata Y, Nishida E.
    FEBS J; 2007 Nov 24; 274(21):5690-703. PubMed ID: 17922836
    [Abstract] [Full Text] [Related]

  • 27. Novel subunits of the mammalian Hsp90 signal transduction chaperone.
    Te J, Jia L, Rogers J, Miller A, Hartson SD.
    J Proteome Res; 2007 May 24; 6(5):1963-73. PubMed ID: 17348703
    [Abstract] [Full Text] [Related]

  • 28. Hsp90 regulates p50(cdc37) function during the biogenesis of the activeconformation of the heme-regulated eIF2 alpha kinase.
    Shao J, Grammatikakis N, Scroggins BT, Uma S, Huang W, Chen JJ, Hartson SD, Matts RL.
    J Biol Chem; 2001 Jan 05; 276(1):206-14. PubMed ID: 11036079
    [Abstract] [Full Text] [Related]

  • 29. Molybdate inhibits hsp90, induces structural changes in its C-terminal domain, and alters its interactions with substrates.
    Hartson SD, Thulasiraman V, Huang W, Whitesell L, Matts RL.
    Biochemistry; 1999 Mar 23; 38(12):3837-49. PubMed ID: 10090774
    [Abstract] [Full Text] [Related]

  • 30. Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1.
    Gaude H, Aznar N, Delay A, Bres A, Buchet-Poyau K, Caillat C, Vigouroux A, Rogon C, Woods A, Vanacker JM, Höhfeld J, Perret C, Meyer P, Billaud M, Forcet C.
    Oncogene; 2012 Mar 22; 31(12):1582-91. PubMed ID: 21860411
    [Abstract] [Full Text] [Related]

  • 31. Functional analysis of the Hsp90-associated human peptidyl prolyl cis/trans isomerases FKBP51, FKBP52 and Cyp40.
    Pirkl F, Buchner J.
    J Mol Biol; 2001 May 11; 308(4):795-806. PubMed ID: 11350175
    [Abstract] [Full Text] [Related]

  • 32. Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37.
    Nony P, Gaude H, Rossel M, Fournier L, Rouault JP, Billaud M.
    Oncogene; 2003 Dec 11; 22(57):9165-75. PubMed ID: 14668798
    [Abstract] [Full Text] [Related]

  • 33. Hsp90 and Cdc37 -- a chaperone cancer conspiracy.
    Pearl LH.
    Curr Opin Genet Dev; 2005 Feb 11; 15(1):55-61. PubMed ID: 15661534
    [Abstract] [Full Text] [Related]

  • 34. Stabilization of integrin-linked kinase by binding to Hsp90.
    Aoyagi Y, Fujita N, Tsuruo T.
    Biochem Biophys Res Commun; 2005 Jun 17; 331(4):1061-8. PubMed ID: 15882985
    [Abstract] [Full Text] [Related]

  • 35. Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex.
    Xu W, Yuan X, Xiang Z, Mimnaugh E, Marcu M, Neckers L.
    Nat Struct Mol Biol; 2005 Feb 17; 12(2):120-6. PubMed ID: 15643424
    [Abstract] [Full Text] [Related]

  • 36. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Dalgarno D, Stehle T, Narula S, Schelling P, van Schravendijk MR, Adams S, Andrade L, Keats J, Ram M, Jin L, Grossman T, MacNeil I, Metcalf C, Shakespeare W, Wang Y, Keenan T, Sundaramoorthi R, Bohacek R, Weigele M, Sawyer T.
    Chem Biol Drug Des; 2006 Jan 17; 67(1):46-57. PubMed ID: 16492148
    [Abstract] [Full Text] [Related]

  • 37. Supervision of multiple signaling protein kinases by the CK2-Cdc37 couple, a possible novel cancer therapeutic target.
    Miyata Y, Nishida E.
    Ann N Y Acad Sci; 2004 Dec 17; 1030():150-7. PubMed ID: 15659792
    [Abstract] [Full Text] [Related]

  • 38. Independent ATPase activity of Hsp90 subunits creates a flexible assembly platform.
    McLaughlin SH, Ventouras LA, Lobbezoo B, Jackson SE.
    J Mol Biol; 2004 Nov 26; 344(3):813-26. PubMed ID: 15533447
    [Abstract] [Full Text] [Related]

  • 39. MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90.
    Ren J, Bharti A, Raina D, Chen W, Ahmad R, Kufe D.
    Oncogene; 2006 Jan 05; 25(1):20-31. PubMed ID: 16158055
    [Abstract] [Full Text] [Related]

  • 40. The chaperone function of cyclophilin 40 maps to a cleft between the prolyl isomerase and tetratricopeptide repeat domains.
    Mok D, Allan RK, Carrello A, Wangoo K, Walkinshaw MD, Ratajczak T.
    FEBS Lett; 2006 May 15; 580(11):2761-8. PubMed ID: 16650407
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.